Jump to content

Biotechnology patent applications on 2025-07-03: Difference between revisions

From WikiPatents
Technology trend analysis for Biotechnology patent applications on 2025-07-03
 
Technology trend analysis for Biotechnology patent applications on 2025-07-03
 
Line 1: Line 1:
= Biotechnology Patent Applications on July 03, 2025 =
= Biotechnology Patent Applications on July 03 2025 =


This page analyzes '''{{formatnum:25}}''' patent applications related to Biotechnology published on July 03, 2025.
== Executive Summary ==
 
On July 03 2025, '''{{formatnum:25}}''' patent applications related to Biotechnology were published, representing 0.3% of all patent applications for the day. While representing a smaller percentage, this activity indicates emerging innovation in Biotechnology.
 
== Market Analysis ==
 
=== Leading Organizations ===
 
The top organizations driving Biotechnology innovation include:
 
* '''[[Trenchant BioSystems, Inc. patent applications on 2025-07-03|Trenchant BioSystems, Inc.]]''': 3 applications (12.0% of Biotechnology patents)
* '''[[Institut Curie patent applications on 2025-07-03|Institut Curie]]''': 1 applications (4.0% of Biotechnology patents)
* '''[[Institut National de la Santé et de la Recherche Médicale patent applications on 2025-07-03|Institut National de la Santé et de la Recherche Médicale]]''': 1 applications (4.0% of Biotechnology patents)
* '''[[SHORELINE BIOSCIENCES, INC. patent applications on 2025-07-03|SHORELINE BIOSCIENCES, INC.]]''': 1 applications (4.0% of Biotechnology patents)
* '''[[SUSTAIN HOLDINGS, LLC patent applications on 2025-07-03|SUSTAIN HOLDINGS, LLC]]''': 1 applications (4.0% of Biotechnology patents)
 
These 5 organizations account for 7 applications (28.0% of all Biotechnology patents), indicating moderate concentration in the field.
 
== Technology Deep Dive ==
 
=== Core Innovation Areas ===
 
Patent applications in Biotechnology encompass several key innovation areas:
 
* '''[https://wikipatents.org/index.php?search=biotechnology Biotechnology]''': Core technology area
* '''[https://wikipatents.org/index.php?search=biotech Biotech]''': Core technology area
* '''[https://wikipatents.org/index.php?search=genetic+engineering Genetic Engineering]''': Core technology area
* '''[https://wikipatents.org/index.php?search=crispr Crispr]''': Core technology area
* '''[https://wikipatents.org/index.php?search=gene+therapy Gene Therapy]''': Core technology area
* '''[https://wikipatents.org/index.php?search=gene+editing Gene Editing]''': Core technology area
* '''[https://wikipatents.org/index.php?search=synthetic+biology Synthetic Biology]''': Core technology area
* '''[https://wikipatents.org/index.php?search=bioinformatics Bioinformatics]''': Core technology area
 
Emerging areas include:
 
* '''[https://wikipatents.org/index.php?search=genomics Genomics]''': Developing technology
* '''[https://wikipatents.org/index.php?search=proteomics Proteomics]''': Developing technology
* '''[https://wikipatents.org/index.php?search=cell+therapy Cell Therapy]''': Developing technology
* '''[https://wikipatents.org/index.php?search=immunotherapy Immunotherapy]''': Developing technology
* '''[https://wikipatents.org/index.php?search=biologics Biologics]''': Developing technology
 
=== Technical Classification Analysis ===
 
The most active CPC classifications in Biotechnology include:
 
* '''[[CPC A61P35/00|A61P35/00]]''' (Antineoplastic agents): 6 applications (24.0%)
* '''[[CPC C12N2310/20|C12N2310/20]]''' (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 4 applications (16.0%)
* '''[[CPC A61K48/0058|A61K48/0058]]''' (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 3 applications (12.0%)
* '''[[CPC C12N15/86|C12N15/86]]''' (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 applications (12.0%)
* '''[[CPC C12N9/22|C12N9/22]]''' (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 applications (12.0%)
* '''[[CPC G16B30/10|G16B30/10]]''' (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 3 applications (12.0%)
* '''[[CPC G16B30/00|G16B30/00]]''' (ICT specially adapted for sequence analysis involving nucleotides or amino acids): 3 applications (12.0%)
* '''[[CPC A61K35/17|A61K35/17]]''' (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
* '''[[CPC A61K40/11|A61K40/11]]''' (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
* '''[[CPC A61K40/31|A61K40/31]]''' (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
 
=== Global Innovation Landscape ===
 
Innovation in Biotechnology spans multiple countries:
 
* '''[[Inventors from US|US]]''': 67 inventors (68.4%)
* '''[[Inventors from KR|KR]]''': 14 inventors (14.3%)
* '''[[Inventors from ES|ES]]''': 4 inventors (4.1%)
* '''[[Inventors from CN|CN]]''': 3 inventors (3.1%)
* '''[[Inventors from FR|FR]]''': 2 inventors (2.0%)
* '''[[Inventors from SE|SE]]''': 2 inventors (2.0%)
* '''[[Inventors from CH|CH]]''': 2 inventors (2.0%)
* '''[[Inventors from DE|DE]]''': 2 inventors (2.0%)
* '''[[Inventors from GB|GB]]''': 1 inventors (1.0%)
* '''[[Inventors from VE|VE]]''': 1 inventors (1.0%)
 
The United States accounts for 68.4% of inventors in Biotechnology, indicating strong domestic innovation leadership.
 
=== Industry Collaborations ===
 
Notable collaborations in Biotechnology include:
 
* '''[[Institut Curie patent applications on 2025-07-03|Institut Curie]]''' × '''[[Institut National de la Santé et de la Recherche Médicale patent applications on 2025-07-03|Institut National de la Santé et de la Recherche Médicale]]''': 1 joint applications
* '''[[The Broad Institute, Inc. patent applications on 2025-07-03|The Broad Institute, Inc.]]''' × '''[[Massachusetts Institute of Technology patent applications on 2025-07-03|Massachusetts Institute of Technology]]''': 1 joint applications
* '''[[The Broad Institute, Inc. patent applications on 2025-07-03|The Broad Institute, Inc.]]''' × '''[[President and Fellows of Harvard College patent applications on 2025-07-03|President and Fellows of Harvard College]]''': 1 joint applications
* '''[[Massachusetts Institute of Technology patent applications on 2025-07-03|Massachusetts Institute of Technology]]''' × '''[[President and Fellows of Harvard College patent applications on 2025-07-03|President and Fellows of Harvard College]]''': 1 joint applications
* '''[[Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. patent applications on 2025-07-03|Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P.]]''' × '''[[Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz patent applications on 2025-07-03|Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz]]''': 1 joint applications
 
These collaborations represent 5 joint applications, indicating strong industry cooperation in Biotechnology.
 
=== Leading Inventors ===
 
Key inventors driving Biotechnology innovation:
 
* '''[[:Category:Jonathan Ellis|Jonathan Ellis]]''': 3 applications
* '''[[:Category:Philip H. Coelho|Philip H. Coelho]]''': 2 applications
* '''[[:Category:Paul Getchel|Paul Getchel]]''': 2 applications
* '''[[:Category:Benjamin T. Edmundson|Benjamin T. Edmundson]]''': 2 applications
* '''[[:Category:Samuel G. Miller|Samuel G. Miller]]''': 2 applications
* '''[[:Category:Duncan MacGregor|Duncan MacGregor]]''': 2 applications
* '''[[:Category:Michael S. Wilk|Michael S. Wilk]]''': 2 applications
* '''[[:Category:Joël Bodenmann|Joël Bodenmann]]''': 2 applications
* '''[[:Category:Pieter Van Rooyen|Pieter Van Rooyen]]''': 2 applications
* '''[[:Category:Michael Ruehle|Michael Ruehle]]''': 2 applications
 
=== Recent Patent Applications ===
 
Representative Biotechnology patent applications from July 03 2025:
 
==== 20250213614. Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon Expression ====
'''Applicant:''' Institut Curie, Institut National de la Santé et de la Recherche Médicale
 
'''Abstract:''' The invention is in the field of immunotherapy. The present application provides modified RELA protein which are useful for inducing or promoting interferon expression by immune cells, in particular T...
 
==== 20250213615. CHIMERIC ANTIGEN RECEPTORS FOR NATURAL KILLER CELLS AND USES THEREOF IN IMMUNOTHERAPY ====
'''Applicant:''' SHORELINE BIOSCIENCES, INC.
 
'''Abstract:''' Provided are natural killer cells engineered to express a chimeric antigen receptor (CAR) with Toll/interleukin-1 (IL-1) receptor (TIR) signaling domains, such as a Toll-like receptor (TLR) signaling ...
 
==== 20250213641. COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF ====
'''Applicant:''' SUSTAIN HOLDINGS, LLC
 
'''Abstract:''' The present invention is in the fields of medicinal chemistry, biotechnology and pharmaceuticals. The invention provides compositions comprising one or more collagen mimetic peptides, optionally attac...
 
==== 20250213689. IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER ====
'''Applicant:''' APGEN THERAPUETICS AB


== Executive Summary ==
'''Abstract:''' The invention relates to the field of immunotherapy, more in particular to a composition for use in the treatment of cancer. The invention also relates to a composition obtainable by such a method, su...
 
==== 20250213695. ULTRASOUND-MEDIATED GENE THERAPY FOR DEEP VEIN THROMBOSIS AND POST-THROMBOTIC SYNDROME ====
'''Applicant:''' Cedars-Sinai Medical Center
 
'''Abstract:''' Systems and methods are provided for ultrasound-based microbubble-assisted or nanobubble-assisted theragnosis, treating, ameliorating, or preventing one or more vascular diseases. In particular, syste...
 
== Market Implications ==


Biotechnology represents 0.3% of all patent applications published on this date, indicating emerging innovation activity in this sector.
=== Innovation Intensity ===


== Key Technology Areas in Biotechnology ==
The 25 applications indicate strong innovation activity in Biotechnology, reflecting sustained R&D investment and market development.


Patent applications in Biotechnology typically involve innovations related to:
=== Competitive Landscape ===


* Biotechnology
Innovation in Biotechnology involves 28 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.
* Biotech
* Genetic Engineering
* Crispr
* Gene Therapy
* Gene Editing
* Synthetic Biology
* Bioinformatics
* Genomics
* Proteomics


== Market and Industry Implications ==
=== Technology Outlook ===


The level of patent activity in Biotechnology suggests:
Emerging themes in Biotechnology patents include: cells, cell, methods, that, cancer, suggesting future development in these areas.


* '''Emerging Field''': Biotechnology represents early-stage innovation
The current patent activity level suggests Biotechnology is in a early development phase with emerging applications and technologies.
* '''Future Potential''': Technology may see increased activity over time
* '''Niche Applications''': Focused on specific use cases or applications


== Related Technology Areas ==
== Related Technology Areas ==


Innovation in Biotechnology often intersects with:
Innovation in Biotechnology often intersects with other emerging technologies:


* [[Augmented Reality patent applications on 2025-07-03|Augmented Reality]] (7256 applications)
* '''[[Augmented Reality patent applications on 2025-07-03|Augmented Reality]]''': 7256 applications
* [[Semiconductors patent applications on 2025-07-03|Semiconductors]] (1504 applications)
* '''[[Semiconductors patent applications on 2025-07-03|Semiconductors]]''': 1504 applications
* [[Medical Devices patent applications on 2025-07-03|Medical Devices]] (235 applications)
* '''[[Medical Devices patent applications on 2025-07-03|Medical Devices]]''': 235 applications
* [[5G Technology patent applications on 2025-07-03|5G Technology]] (177 applications)
* '''[[5G Technology patent applications on 2025-07-03|5G Technology]]''': 177 applications
* [[Generative AI patent applications on 2025-07-03|Generative AI]] (115 applications)
* '''[[Generative AI patent applications on 2025-07-03|Generative AI]]''': 115 applications
* '''[[Renewable Energy patent applications on 2025-07-03|Renewable Energy]]''': 95 applications
* '''[[Autonomous Vehicles patent applications on 2025-07-03|Autonomous Vehicles]]''': 86 applications
* '''[[Cybersecurity patent applications on 2025-07-03|Cybersecurity]]''': 76 applications


== Innovation Timeline and Trends ==
== Analysis Tools ==


Patent applications in Biotechnology reflect ongoing technological development cycles:
=== Search Resources ===


* '''Current Activity''': 25 applications published on July 03, 2025
* [https://wikipatents.org/index.php?search=Biotechnology+20250703 Search all Biotechnology patents from July 03 2025]
* '''Technology Maturity''': Emerging stage
* [https://wikipatents.org/index.php?search=Biotechnology Browse all Biotechnology patents]
* '''Innovation Intensity''': Moderate volume of new applications
* [[Special:CategoryTree/Biotechnology Patent Applications|Browse by category]]


== See Also ==
== See Also ==


* [[Weekly Patent Application Summary]]
* [[20250703 Patent Applications Report for July 03 2025|Weekly Patent Summary]]
* [[Technology Trends in Patent Applications]]
* [[Technology Trends in Patent Applications]]
* [[Biotechnology Industry Analysis]]
* [[Biotechnology Industry Analysis]]
* [[Patent Analytics and Trends]]


[[Category:Biotechnology]]
[[Category:Biotechnology]]
[[Category:Biotechnology Patent Applications]]
[[Category:Biotechnology Patent Applications]]
[[Category:Technology Trends 2025]]
[[Category:Technology Trends 2025]]
[[Category:Patent Applications July 03, 2025]]
[[Category:Patent Applications July 03 2025]]
[[Category:Weekly Reports 2025]]

Latest revision as of 16:06, 7 July 2025

Biotechnology Patent Applications on July 03 2025

Executive Summary

On July 03 2025, 25 patent applications related to Biotechnology were published, representing 0.3% of all patent applications for the day. While representing a smaller percentage, this activity indicates emerging innovation in Biotechnology.

Market Analysis

Leading Organizations

The top organizations driving Biotechnology innovation include:

These 5 organizations account for 7 applications (28.0% of all Biotechnology patents), indicating moderate concentration in the field.

Technology Deep Dive

Core Innovation Areas

Patent applications in Biotechnology encompass several key innovation areas:

Emerging areas include:

Technical Classification Analysis

The most active CPC classifications in Biotechnology include:

  • A61P35/00 (Antineoplastic agents): 6 applications (24.0%)
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 applications (16.0%)
  • A61K48/0058 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 3 applications (12.0%)
  • C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 applications (12.0%)
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 applications (12.0%)
  • G16B30/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 3 applications (12.0%)
  • G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids): 3 applications (12.0%)
  • A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
  • A61K40/11 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)
  • A61K40/31 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 applications (8.0%)

Global Innovation Landscape

Innovation in Biotechnology spans multiple countries:

  • US: 67 inventors (68.4%)
  • KR: 14 inventors (14.3%)
  • ES: 4 inventors (4.1%)
  • CN: 3 inventors (3.1%)
  • FR: 2 inventors (2.0%)
  • SE: 2 inventors (2.0%)
  • CH: 2 inventors (2.0%)
  • DE: 2 inventors (2.0%)
  • GB: 1 inventors (1.0%)
  • VE: 1 inventors (1.0%)

The United States accounts for 68.4% of inventors in Biotechnology, indicating strong domestic innovation leadership.

Industry Collaborations

Notable collaborations in Biotechnology include:

These collaborations represent 5 joint applications, indicating strong industry cooperation in Biotechnology.

Leading Inventors

Key inventors driving Biotechnology innovation:

Recent Patent Applications

Representative Biotechnology patent applications from July 03 2025:

20250213614. Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon Expression

Applicant: Institut Curie, Institut National de la Santé et de la Recherche Médicale

Abstract: The invention is in the field of immunotherapy. The present application provides modified RELA protein which are useful for inducing or promoting interferon expression by immune cells, in particular T...

20250213615. CHIMERIC ANTIGEN RECEPTORS FOR NATURAL KILLER CELLS AND USES THEREOF IN IMMUNOTHERAPY

Applicant: SHORELINE BIOSCIENCES, INC.

Abstract: Provided are natural killer cells engineered to express a chimeric antigen receptor (CAR) with Toll/interleukin-1 (IL-1) receptor (TIR) signaling domains, such as a Toll-like receptor (TLR) signaling ...

20250213641. COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

Applicant: SUSTAIN HOLDINGS, LLC

Abstract: The present invention is in the fields of medicinal chemistry, biotechnology and pharmaceuticals. The invention provides compositions comprising one or more collagen mimetic peptides, optionally attac...

20250213689. IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER

Applicant: APGEN THERAPUETICS AB

Abstract: The invention relates to the field of immunotherapy, more in particular to a composition for use in the treatment of cancer. The invention also relates to a composition obtainable by such a method, su...

20250213695. ULTRASOUND-MEDIATED GENE THERAPY FOR DEEP VEIN THROMBOSIS AND POST-THROMBOTIC SYNDROME

Applicant: Cedars-Sinai Medical Center

Abstract: Systems and methods are provided for ultrasound-based microbubble-assisted or nanobubble-assisted theragnosis, treating, ameliorating, or preventing one or more vascular diseases. In particular, syste...

Market Implications

Innovation Intensity

The 25 applications indicate strong innovation activity in Biotechnology, reflecting sustained R&D investment and market development.

Competitive Landscape

Innovation in Biotechnology involves 28 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.

Technology Outlook

Emerging themes in Biotechnology patents include: cells, cell, methods, that, cancer, suggesting future development in these areas.

The current patent activity level suggests Biotechnology is in a early development phase with emerging applications and technologies.

Related Technology Areas

Innovation in Biotechnology often intersects with other emerging technologies:

Analysis Tools

Search Resources

See Also

Retrieved from "https://wikipatents.org/index.php?title=Biotechnology_patent_applications_on_2025-07-03&oldid=663062"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.